Form D · Biotechnology
BIOMIMETIC THERAPEUTICS, INC.
Franklin, TN · CIK 0001138400
Offering snapshot reported Jul 10, 2009 · SEC filing
- Reported sold
- $2.92M Offering amount: $2.92M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 25, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 10, 2009 | Initial | $2,918,951 | No comparison | 1 | SEC filing |
| Apr 21, 2009 | Initial | $8,000,004 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-55779
Source: Form D, filed Jul 10, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Larry Bullock | Executive |
| Thorkil Christensen | Director |
| Earl Douglas | Executive |
| Chris Ehrlich | Director |
| Charles Federico | Director |
| Gary Friedlaender | Director |
| Steven Hirsch | Executive |
| Samuel Lynch | Director, Executive |
| James Murphy | Director |
| Russ Pagano | Executive |
| Larry Papasan | Director |
| Douglas Watson | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
389 Nichol Mill Lane
Franklin, TN, 37067
Franklin, TN, 37067